Assessment of Immuno-histochemical Expression of CD44 in Renal Tumors
Background: Cluster of differentiation 44 (CD44) is the most commonly reported immune marker of the cancer stem cells in renal cell carcinoma.Objectives: To assess the frequency of CD44 expression in renal tumors, to assess the expression of CD44 in different histological types, and to detect its as...
Saved in:
Main Authors: | Banan Mohammed, khalid Abdulfattah Khattab, Payman Salim |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Anbar
2025-01-01
|
Series: | Al-Anbar Medical Journal |
Subjects: | |
Online Access: | https://amj.uoanbar.edu.iq/article_185669_8dfa3277d44fd3b065a7b6a6baf38114.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Evaluation of CD10 and HER2 Immunohistochemical Markers in Urothelial Carcinoma of Urinary Bladder
by: Khalid W. Abdulfattah Khattab, et al.
Published: (2024-12-01) -
Investigation of CD47 Expression in Renal Cell Tumors and Evaluation of Its Relationship with Prognostic Parameters
by: Ömer Faruk Dizibüyük, et al.
Published: (2024-12-01) -
Evaluating the role of CD44 in oral squamous cell carcinoma and potentially malignant disorders – An immunohistochemical study
by: Tharani V, et al.
Published: (2024-06-01) -
Single-cell and spatial transcriptomics reveal SPP1-CD44 signaling drives primary resistance to immune checkpoint inhibitors in RCC
by: Junfeng Zhang, et al.
Published: (2024-12-01) -
The role of ESRP1 in solid tumor development through the regulation of CD44 splicing and EMT processes
by: Lili Wang, et al.
Published: (2025-02-01)